Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-10 2:03 pm Purchase | 13G | Moderna Inc. MRNA | VANGUARD GROUP INC | 39,036,765 10.200% | 5,129,791 (+15.13%) | View |
| 2024-02-13 5:09 pm Purchase | 13G | Moderna Inc. MRNA | VANGUARD GROUP INC | 33,906,974 8.890% | 6,624,801 (+24.28%) | View |
| 2024-02-07 08:42 am Purchase | 13G | Moderna Inc. MRNA | Bancel Stephane | 30,384,866 7.800% | 1,233,064 (+4.23%) | View |
| 2024-01-29 3:26 pm Sale | 13G | Moderna Inc. MRNA | BlackRock Inc. BLK | 25,301,057 6.600% | -814,167 (-3.12%) | View |
| 2024-01-29 10:49 am Purchase | 13G | Moderna Inc. MRNA | BAILLIE GIFFORD & CO | 45,654,527 11.970% | 867,781 (+1.94%) | View |
| 2023-02-10 4:42 pm Sale | 13G | Moderna Inc. MRNA | Bancel Stephane | 29,151,802 7.410% | -2,386,382 (-7.57%) | View |
| 2023-02-09 11:27 am Sale | 13G | Moderna Inc. MRNA | VANGUARD GROUP INC | 27,282,173 7.100% | -144,397 (-0.53%) | View |
| 2023-01-31 5:52 pm Sale | 13G | Moderna Inc. MRNA | BlackRock Inc. BLK | 26,115,224 6.800% | -1,546,249 (-5.59%) | View |
| 2023-01-19 11:25 am Sale | 13G | Moderna Inc. MRNA | BAILLIE GIFFORD & CO | 44,786,746 11.660% | -985,333 (-2.15%) | View |
| 2022-02-14 3:00 pm Sale | 13G | Moderna Inc. MRNA | Flagship Ventures Fund IV General Partner LLC | 20,008,540 4.900% | -13,134,971 (-39.63%) | View |
| 2022-02-14 08:01 am Purchase | 13G | Moderna Inc. MRNA | Bancel Stephane | 31,538,184 7.640% | 2,878,726 (+10.04%) | View |
| 2022-02-10 08:27 am Purchase | 13G | Moderna Inc. MRNA | VANGUARD GROUP INC | 27,426,570 6.760% | 4,054,715 (+17.35%) | View |
| 2022-02-04 4:12 pm Purchase | 13G | Moderna Inc. MRNA | BlackRock Inc. BLK | 27,661,473 6.800% | 8,270,748 (+42.65%) | View |
| 2022-01-26 10:26 am Purchase | 13G | Moderna Inc. MRNA | BAILLIE GIFFORD & CO | 45,772,079 11.290% | 1,080,693 (+2.42%) | View |
| 2021-07-12 08:29 am Sale | 13G | Moderna Inc. MRNA | BlackRock Inc. BLK | 19,390,725 4.800% | -1,085,989 (-5.30%) | View |
| 2021-03-01 11:26 am Purchase | 13G | Moderna Inc. MRNA | BAILLIE GIFFORD & CO | 44,691,386 11.180% | 20,379,115 (+83.82%) | View |
| 2021-02-16 5:02 pm Sale | 13G | Moderna Inc. MRNA | Flagship Ventures Fund IV General Partner LLC | 33,143,511 8.400% | -17,865,181 (-35.02%) | View |
| 2021-02-12 08:00 am Sale | 13G | Moderna Inc. MRNA | Bancel Stephane | 28,659,458 7.090% | -2,940,318 (-9.30%) | View |
| 2021-02-10 4:01 pm Sale | 13G | Moderna Inc. MRNA | ASTRAZENECA PLC AZN | 0 0.000% | -25,499,325 (Position Closed) | View |
| 2021-02-10 11:28 am Purchase | 13G | Moderna Inc. MRNA | VANGUARD GROUP INC | 23,371,855 5.910% | 6,052,818 (+34.95%) | View |